Navigation Links
Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
Date:9/13/2012

s of our development program, we are pleased to have the ongoing support of the U.S. Government to evaluate not only IV administration but also the more rapid, cost-effective IM administration of ETI-204," said Elizabeth Posillico, PhD, President and Chief Executive Officer of Elusys. "Advancing the development of both IV and IM administration of our anti-toxin could provide two important options in the prevention and treatment of inhalational anthrax following a biowarfare attack."

Elusys continues to work closely with the U.S. Food and Drug Administration (FDA) on the design of the ETI-204 Phase 3 development program in preparation for an anticipated End of Phase 2 meeting. ETI-204 was granted Fast Track status and Orphan Drug Designation in 2006 by the FDA.

About ETI-204

ETI-204 is a high-affinity, humanized and deimmunized monoclonal antibody that targets the protective antigen of B. anthracis and neutralizes the lethal effects of anthrax toxins by binding to Protective Antigen.  It is an investigational agent being developed for treatment of inhalational anthrax following a biowarfare attack.

ETI-204 efficacy and safety are being studied in animals and safety studies are being conducted with human volunteers. To date, five studies assessing the efficacy and safety of ETI-204 in animals with inhalational anthrax have been completed, and three studies assessing pharmacokinetics and safety of IV administration of ETI-204 in humans have been conducted. In the two completed studies, the adverse event profile of ETI-204 was comparable to placebo and the more common adverse events related to ETI-204 administration were headache and upper respiratory tract infection. ETI-204 is formulated as a solution suitable for either IV or IM administration. This program is supported with federal funds from the Office of the Assistant
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
2. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
3. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
4. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
5. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
6. Turner Construction Company Awarded Fort Irwin Replacement Hospital
7. Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
8. Texas A&M System Awarded National Center for Innovation
9. Sorrento Therapeutics Awarded Third Phase I STTR Grant
10. SurgiCount Medical Awarded Contract From HealthTrust Purchasing Group for the Safety-SpongeĀ® System
11. New Chronic Wound Therapy Awarded at Texas Largest Life Science Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
(Date:1/14/2014)... 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System ... accompanying instrumentation to place and insert the screw accurately ... tissue (e.g. ligament) repair or reconstruction as it holds ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The ...
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , Inc., ... its Innovation Leadership Summit , May 14-16, 2014 ... Cleveland Ohio . This ... organizations committed to breakthrough achievements through open innovation. Participants ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... , NEW YORK, Dec. ... report is available in its catalogue: , Ambulatory ... , http://www.reportlinker.com/p0164274/Ambulatory-and-Bathroom-Aids---A-Worldwide-Market-Review.html , Globally consumer spending on ... by steadily ageing population and rise in diseases associated ...
... ... a new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164337/Radiation-Therapy-Equipment---A-Global-Market-Review.html , Cancer ... cancer cases diagnosed each year. Radiation therapy is the ...
Cached Medicine Technology:Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8
(Date:7/9/2014)... Health Organization recommends that youth participate in a minimum ... (MVPA) each day. Studies have shown that youth ... Therefore, it stands to reason that increasing outdoor time ... new study scheduled for publication in The Journal ... after school was positively associated with MVPA. , Drs. ...
(Date:7/9/2014)... July 10, 2014 For the first time, researchers ... Aboriginal population in Canada uses health care. A new ... to clearly demonstrate the unique challenges faced by urban ... St. Michael,s Hospital. , The findings, published today ... urban First Nations individuals and the general population. , ...
(Date:7/9/2014)... School of Medicine at the University of Pennsylvania in ... an $8 million grant from the National Cancer Institute ... (PDT) in patients with malignant pleural mesothelioma, a rare, ... in the lining of the lungs and is caused ... fund a clinical trial and additional studies looking at ...
(Date:7/9/2014)... network of signals active in almost all types of ... overdrive, and may help fuel a tumour,s uncontrolled growth, ... Cancer Research, London, identified a molecular trigger responsible for ... the cellular factory that makes the building blocks cancer ... the TOR signalling pathway, called SREBP, controls the flow ...
(Date:7/9/2014)... Studying the most common type of lung cancer, researchers ... a role in forming tumors. The new knowledge may ... these genetic changes already are available or are in ... , investigators from The Cancer Genome Atlas (TCGA), including ... Louis, Harvard Medical School and other institutions, studied tumors ...
Breaking Medicine News(10 mins):Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Urban Aboriginal people face unique health challenges 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Lung cancer study hints at new treatments 2
... for hepatitis C patients with end-stage liver disease are nearly ... to a Henry Ford Hospital study. Although infection ... the specific impact of the disease,s progressive severity on health ... severity of hepatitis C-related liver disease increases with age, and ...
... patients in Canada undergo breast reconstruction after mastectomy, despite ... benefits, states a review article in CMAJ ... rates of breast reconstruction and factors that influence the ... breast cancer. However, information is lacking on the current ...
... -- In a study to be published online Nov. 6 ... School of Medicine have shown that the development of osteoarthritis ... is at odds with the prevailing view attributing the condition ... "It,s a paradigm change," said William Robinson, MD, PhD, ...
... know what cell types to become? Why do cells in ... into cancer cells? These are some of the questions intensively ... has a very strong position internationally and one of the ... Copenhagen. She has just received an ERC Starting Grant and ...
... A comprehensive four-year project including over 10,000 patients in ... visceral leishmaniasis (VL, also known as kala-azar) in India ... last month to support control and elimination strategies in ... among the world,s highest. The Drugs for ...
... CHICAGO Among patients with juvenile idiopathic arthritis (JIA) ... an excellent response, and this response was associated with ... at the onset of JIA, and fewer disease-modifying antirheumatic ... appearing in JAMA . The study is being ...
Cached Medicine News:Health News:The economic cost of advanced liver disease 2Health News:Rates of breast reconstruction after mastectomy in Canada 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 3Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 4Health News:Research in cellular memory 2Health News:Major project to implement new treatments to boost kala-azar elimination strategies 2Health News:Major project to implement new treatments to boost kala-azar elimination strategies 3Health News:Study identifies factors linked with better medication response for treatment of juvenile arthritis 2Health News:Study identifies factors linked with better medication response for treatment of juvenile arthritis 3
... generators are meeting the clinical needs ... and anesthesiologists. And, they are of ... from Medtronic.,Effective pacing with the adjustment ... for quick battery changes. Both ...
... CardioVad is a unique left ventricular assist device ... It is being used in a small group ... as part of an FDA-approved Feasibility Study. The ... the external power source for minutes or hours. ...
... Inc. has introduced the world's first minimally-invasive ... 10626 Epicardial Lead Implant Tool, which has ... States, will expand the options available to ... 5071 lead on the heart during pacemaker ...
The Schiller treadmill ergometer is designed for stress tests, sports medicine and cardiology. It is equipped and tested with the latest safety system and has been manufactured under the stringent qu...
Medicine Products: